leveraged buyout

NEW YORK (GenomeWeb News) – Citing a recent run up in Life Technologies' stock fueled by speculation that it may be positioning itself to be bought, investment bank Cowen & Co. today downgraded the Carlsbad, Calif.-based firm to Neutral from Outperform.

NEW YORK (GenomeWeb News) – Despite a report that a group of private equity firms were banding together to possibly acquire Life Technologies, shares of the Carlsbad, Calif.-based firm fell today.

NEW YORK (GenomeWeb News) – Shares of Life Technologies fell 7 percent in early Wednesday trade after a report from Reuters that potential acquirers for the firm have cooled

NEW YORK (GenomeWeb News) – Fitch Ratings today placed Life Technologies' ratings on Rating Watch Evolving following a report two weeks ago that the Carlsbad, Calif.-based firm may be looki

NEW YORK (GenomeWeb News) – Following a spike in Life Technologies' share price after a report that the company may be searching for a buyer, investment firm William Blair today downgra

NEW YORK (GenomeWeb News) – Shares of Life Technologies jumped 17 percent in Friday morning pre-market trading on reports that the firm may be seeking to sell itself.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.